PKM and cerebral small vessel disease: Circulatory PKM2 has been suggested as a potential biomarker for coronary disease and sepsis (Wang et al., 2023; Zhao et al., 2024) and was associated with cognitive function in people with cerebral small vessel disease (Bian et al., 2023).